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Abstract
Beginning in 2001, the Dominican Republic experienced a series of healthcare reforms
contributing to the current structure of the Dominican healthcare system, influencing access to
specialized type 1 diabetes (T1D) care, affordable insulin and medications, and diabetes
education. As type 1 diabetes is a misunderstood and understudied issue in the Dominican
Republic, the goals of this research are twofold. First, this project situates T1D care in the
context of the Dominican healthcare system, analyzing its impact on T1D patients. Second, it
addresses how the Dominican Republic can better meet the health-related needs of its citizens
who have type 1 diabetes through various T1D policies, programs, and investments. A
comparison of case studies from the United States, Colombia, Ecuador, and a nine-country
cross-regional analysis will highlight successful solutions that have increased access to T1D
healthcare resources, providing alternative solutions applicable to the DR. Utilizing theories of
healthcare accessibility defined by dimensions of approachability, acceptability, availability, and
accommodation, affordability, and appropriateness, this thesis analyzes accessibility to T1D
resources in the Dominican Republic, while simultaneously providing solutions for these gaps in
care.

Keywords: type 1 diabetes/juvenile diabetes/diabetes mellitus, endocrinology, Dominican
Republic, healthcare accessibility, medication affordability, insulin affordability
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Introduction
As a disease that represents 5% of those with diabetes, there is little research and
discussion surrounding type 1 diabetes (T1D) globally, especially within the context of the
Dominican Republic. Since the 1990s, there has been no published data on T1D incidence rates
in the DR, however, estimates based on global increasing trends suggest that the amount of
youth and young adults diagnosed with type 1 diabetes is increasing in the Dominican Republic
(Gutiérrez Martinez, et al., 2021). For context, T1D is an autoimmune condition in which the
immune system attacks insulin-producing cells in the pancreas, leaving the body with no cells to
naturally produce hormones, impacting metabolism, microbiome, genome, and immune
systems in the body (DiMeglio, et al., 2018). T1D is unpreventable and incurable, and successful
management requires constant monitoring of blood glucose levels through glucose testing and
insulin injections or insulin pump therapy. Due to the complicated nature of care for individuals
living with type 1 diabetes, compiling and understanding data specific to type 1 diabetes is
integral, as patients with T1D are more likely than patients with type 2 diabetes to experience
severe episodes of hospitalization, hypoglycemia, or DKA (diabetic ketoacidosis), along with
long term health complications that burden both patients and health systems (Duska, et al.,
2021).
As an issue with scarce research, it is important to provide an analysis that draws
connections between the function of the Dominican healthcare system and its
underinvestment, the impacts of chronic health conditions on medication affordability,
endocrinologist access, geographic barriers, and overall high medication costs. With high health
implications, costs, and impacts on economic well-being, it is important for research to
emphasize the issues that type 1 diabetes patients are facing within the healthcare system. By
examining which aspects of the Dominican healthcare system benefit T1D patients, this
research can also identify which areas need improvements. This research will address the
primary research questions: How does the Dominican healthcare system impact Dominican
patients living with type 1 diabetes (T1D)? The following research will further analyze this issue
and address how the Dominican Republic can better meet the health-related needs of its citizens
who have type 1 diabetes.
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The current healthcare system does not adequately support people with chronic
conditions like T1D due to barriers to accessing care. The DR only invests 6.1% of its GDP into
the healthcare system, less than the average investment in other Latin American countries (8%),
and comparatively globally (9.9%) (Gutierrez Martinez et. al, 2021). From high out-of-pocket
costs for medications to urbanized centers of care, patients that rely solely on the public health
system in the Dominican Republic will not achieve target T1D goals in the same way that those
with private health insurance and external resources outside of the public health system do. For
people living with chronic health conditions like type 1 diabetes (T1D), inadequate care and
higher out-of-pocket healthcare costs can result in lower quality of life, less adherence to
treatment plans, and worsened long-term outcomes (Gutierrez Martinez et. al, 2021).
The structure of the Dominican healthcare system is not supportive of the healthcare
needs of patients with type 1 diabetes due to high out-of-pocket costs for supplies, geographic
barriers to care, and overall underinvestment in the DR healthcare system. This project will
emphasize the specific barriers to accessing T1D care for T1D patients in the DR and additional
analysis will expand on solutions that can provide better care to T1D patients. Solutions to these
issues include the implementation and funding of diabetes education programs, the creation of
primary care provider (PCP) training programs, and the implementation of virtual healthcare.
This paper will begin by examining the state of type 1 diabetes in the DR followed by a
brief historical, political, and economic context of the Dominican Republic, in particular,
highlighting the structure and function of the healthcare system. After understanding the
conditions that create these inequities, an analysis of implemented solutions within other Latin
American countries will aid in providing recommendations for policy initiatives or programs that
the DR can implement to better serve their T1D population. This research draws on empirical
studies on type 1 diabetes patients in the DR, as well as existing data from organizations like the
World Health Organization and the World Bank, further complemented by analyses of the
existing state of the Dominican health system. Case studies of Colombia, Ecuador, and the
United States as well as a cross-regional comparison of diabetes care in nine Latin American
countries, provide a robust analysis of potential solutions to these T1D care issues in the DR.
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Academic Context
Research Design and Methods
This research addresses the subject of type 1 diabetes (T1D) healthcare within the
Dominican Republic. T1D patient metrics of income and socioeconomic status, instances of
hospitalization related to T1D, HbA1c values, and costs paid for T1D care are analyzed. This
subject also includes the role of medical research, medical professionals, and education in type
1 diabetes care. The primary object of this study is healthcare accessibility, further defined by
inequality in access to doctors/medical professionals, medical supplies, and essential
treatments.
Three dimensions give additional focus to this case study. The first is the local-global
continuum and its relation to the interconnectedness of type 1 diabetes care within the
Dominican Republic and other countries globally. Local issues can be studied at any point almost
anywhere in time on a global scale (Darian-Smith & McCarty, 2017, 183). While there are issues
of T1D care that are specific to the Dominican Republic, they exist in other regions of the world
as well. This further illustrates the interconnectedness and relatedness of this issue with much
broader implications. A geographic dimension of this case study is the analysis of the
rural-urban divide. While the Dominican Republic is a relatively small country geographically,
location becomes an integral part of accessing healthcare. Similarly, socio-economic status or
class as a socio-political issue becomes an impactful factor in determining the individual-factor
levels that dictate access to care. With high costs associated with high levels of T1D care,
supplies, and insulin, class and one’s ability to afford healthcare greatly impacts healthcare
accessibility in the DR.
On a personal, ethical note, the researcher lives with type 1 diabetes and has personal
experience with the healthcare system in the United States that may influence their view of
type 1 diabetes healthcare systems globally. They have also volunteered in the Dominican
Republic working in diabetes education camps with the non-governmental organizations AYUDA
(American Youth Understanding Diabetes Abroad) and Aprendiendo A Vivir (AAV). Currently, the
researcher is involved with the College Diabetes Network (CDN), JDRF (Juvenile Diabetes
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Research Foundation), and T1International in volunteer capacities. None of this research was
funded by these organizations nor influenced by them.
Demonstrating the relevance of this research outside of the Dominican Republic,
multiple case studies are analyzed, examining the potential solutions for specific T1D issues. A
brief nine-country comparison includes countries of Argentina, Chile, Colombia, Dominican
Republic, Ecuador, Guatemala, Mexico, Panama, and Venezuela. This study examines the impact
of diabetes education, self-management, health insurance, and glycemic control on type 1
diabetes patients. The United States and Ecuador will be compared through the lens of
potential policy analysis, looking at solutions for primary care provider (PCP) training as a
solution for rural T1D healthcare inequities in the DR. Colombia will be compared for its
diabetes education programs and virtual training programs for T1D patients. While all countries
may not be directly comparable based on government systems, healthcare systems, etc., a
general geographic focus on the Latin American region is used. While the countries in this
region are not necessarily directly comparable, in many ways, a comparison can be based on the
geographic hemispheric location, general commonality of language, and other factors that
create a more solid comparison than other regions in the world. This research aims to bring
together the main issues that T1D patients in the DR face and discern whether external
solutions implemented in other countries could positively impact Dominican T1D patients.
This case study will primarily use secondary data rather than primary data sources. The
sources primarily are non-governmental research reports, studies from scholarly journals,
governmental reports, and governmental websites (on healthcare resources). The data collected
is primarily quantitative, highlighting patient demographics, statistics, and reports on the
success (or failure) of various policies and programs addressing T1D care. Much of the
quantitative data highlights income levels, instances of hospitalization, HbA1c values, types of
insulin used, % of income used on T1D supplies, and other factors that expand on access to T1D
care. The qualitative data used is from the Dominican government, such as the Dominican
constitution, specific insurance and healthcare systems, and health policies. This data is used to
supplement the quantitative data and create a deeper understanding of type 1 diabetes care
situated within the Dominican healthcare system.
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Addressing the impacts of the Dominican healthcare system on Dominican T1D patients
requires an analysis of both quantitative and qualitative data. This data will first provide a base
understanding of the specific issues within the DR (high costs, geographic barriers, high
socioeconomic inequities, etc.), before comparing external cases and how other countries are
increasing access to specialized type 1 diabetes professionals, diabetes education, and
accessible and affordable insulin and supplies. This diversity in sources allows for a more robust,
well-rounded analysis of T1D care, as a mix of both quantitative and qualitative data provides a
deeper analysis of an understudied issue.
Since little T1D data in the DR exists, much of the data on type 1 diabetes is from three
studies. Data about the healthcare system (outside of type 1 diabetes healthcare) complements
this. Additionally, many sources that would provide patient data are not available online. Other
limitations include the researcher’s background, as while they have an understanding of type 1
diabetes and type 1 diabetes care in general, they are not medical professionals or a scientific
researcher. Similarly, they are not Dominican and while proficient in Spanish, are not a native
Spanish-speaker. While these limitations do not disqualify this research, they do highlight the
potential for research that could further complement any findings.

Theoretical Framework
Conceptual Dimensions of Accessibility
Before discussing accessible healthcare in the Dominican Republic, it is important to
provide a clear definition of what accessibility is. Defined through the concepts posited by
Penchansky and Thomas in their original definition of the concept of access, and further
expanded by Levesque, Harris, & Russell, accessibility consists of five dimensions. The
overarching definition of accessibility is the opportunity for one to reach necessary healthcare
services, yet it is further defined through dimensions of approachability; acceptability;
availability and accommodation; affordability, and appropriateness (Levesque, et al., 2013).
Further breaking down these components of healthcare accessibility, dimensions include the
ability to perceive, ability to seek, ability to reach, ability to pay, and ability to engage (Levesque,
et al., 2013). These dimensions of healthcare accessibility broadly apply to all healthcare
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systems, including the current structure in the Dominican Republic. This idea is further
illustrated in the diagram below (Diagram 1) with each of the five dimensions outlined
highlighting the patient's ability to access health services.

Diagram 1: Patient-centred access to health care: conceptualizing access at the interface of
health systems and populations (Levesque, et al., 2013)

Approachability emphasizes the ability of patients to identify services that can be
reached with an impact on the health of the individual (Levesque, et al., 2013). Depending on
the patient’s background, services may be more known or less known, with elements such as
transparency and outreach that can make services more or less approachable to patients
(Levesque, et al., 2013). It also relates to the patient’s knowledge of systems and their trust or
beliefs about them (Levesque, et al., 2013). Acceptability focuses on the patient’s cultural and
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social background and these individual-level factors that could impact both accessing care from
the patient perspective and providing care from the medical professional perspective (Levesque,
et al., 2013, Penchansky, et al., 1981). This concept is generally used to emphasize the
relationship between providers and patients and their perceptions of one another, as providers
may unconsciously prefer patients from some groups over others (i.e. not taking welfare
patients), influencing their level of availability accordingly (Penchansky, et al., 1981). In
accessing care, patients’ perceptions of healthcare options, individual rights, and
autonomy/capacity to seek care greatly impact their accessibility, particularly for those in
socioeconomically disadvantaged and vulnerable populations (Levesque, et al., 2013).
Availability and accommodation refer to the act of reaching a health service (the
physical space, providers themselves), in an efficient manner (Levesque, et al., 2013).
Delineating both of these, availability would analyze the existing, available resources compared
to patient needs, while accommodation is the relationship between ease of patient entry into
health systems (appointment systems, hours of operation, geographic barriers, patient mobility,
etc.) and the patient’s ability to accommodate these aspects (Penchansky, et al., 1981).
Affordability is most often the aspect of accessibility discussed, as it is often the biggest
barrier for people of all socioeconomic backgrounds, however, defined, affordability is the
economic ability for people to spend resources using services (Levesque, et al., 2013).
Expanding on this concept, affordability is specifically the relationship between costs of goods
and services concerning insurance or co-pay requirements, and the patient’s ability to pay
(dictated by income, health insurance, etc.) (Penchansky, et al., 1981). Generally, measures of
affordability include the price of care, time traveled to receive care, patient income, opportunity
costs (for receiving care vs. not), quality of care, and provider behavior (Levesque, et al., 2013).
One concept of affordability that is relatively unknown is the patient’s perception of the worth
of services relative to costs, as with higher costs, obtaining services becomes less worthwhile
for patients with lower socioeconomic backgrounds (Penchansky, et al., 1981). Lastly,
appropriateness is the fit between services offered and patient needs, efficiency, and the
quality of care received (Levesque, et al., 2013). The quality of health services is measured in
ways that provide integrated, continuous care, ensuring that patients have access to care that is
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appropriate for the patient (Levesque, et al., 2013). Under this dimension, patients should be
engaged in their care, empowered with support from the medical system while also receiving
high-quality care (technical and interpersonal) (Levesque, et al., 2013).
Not an exhaustive list, each of these dimensions provides an aspect of accessing
healthcare that highlights the individual-level, and system-level factors that dictate access. From
high costs to geographic barriers, each of these issues intersect with one another to contribute
to inaccessible or highly accessible levels of care. The theory from Levesque, et al., 2013,
expands on previous theories, most notably from Penchansky, et al., 1981, to create an analysis
of the accessibility framework through the timeline process for patients seeking care (as
demonstrated in Diagram 1 above). The following research on type 1 diabetes in the Dominican
Republic aims to rectify these issues of inaccessibility found in the DR through a combination of
approaches primarily based on these five dimensions of access.

Type 1 and Type 2 Diabetes Literature
While type 2 diabetes is relatively well-studied in the Dominican Republic (DR), there is
little existing research and discussion surrounding type 1 diabetes in the DR, especially when
analyzing research that attempts a nuanced approach of policy and program analysis to improve
health conditions for those living with type 1 diabetes. This research will highlight the little
existing data on type 1 diabetes in the DR and will primarily analyze what factors contribute to
the overall lacking care for type 1 diabetics in the DR.
In the Dominican Republic, there are two main issues surrounding diabetes data and
research. The first is the aggregation of data on both type 1 diabetes and type 2 diabetes.
Studies focusing on type 2 diabetes in the Dominican Republic have highlighted the prevalence
rate of diabetes as 11%, or around 1 million of the DR’s population (Dethlefs, et al., 2018), with
complications of diabetes such as ischemic heart disease and cerebrovascular disease
contributing to 57.87% of premature deaths in the DR (Dethlefs et al., 2019). While these
studies highlight important diabetes statistics within the Dominican Republic, their data
combines both type 1 diabetes and type 2 diabetes, contributing to an overemphasis on
“diabetes” as type 2 diabetes and the continuation of research and support to highlight type 2

12
over type 1. When researching type 1 diabetes data sources, it is common to see footnotes that
explain there is no separation between type 1 and type 2 diabetes (Wild, et al., 2004), which
contributes to type 1 diabetes data being used inaccurately. For instance, findings will conclude
that the “diabetes epidemic” will continue as obesity levels remain constant (Wild, et al., 2004),
or that access to healthy food and exercise is a priority in lessening diabetes prevalence in the
DR (Dethlefs, et al., 2018), however, these findings are based on type 2 diabetes, yet continue to
aggregate both data sources to inform findings.
The aggregation of type 1 and type 2 diabetes is a prominent issue because type 1
diabetes is not caused by a lack of exercise, diet choices, or other lifestyle factors, but is an
autoimmune condition that is unpreventable and incurable. While type 2 diabetes can be
prevented by lifestyle choices and the impact of the disease can be lessened by medication and
lifestyle habits, people with type 1 diabetes must rely on insulin for the remainder of their life as
their pancreas no longer functions at all. People with type 2 diabetes generally can still produce
insulin and with the assistance of a medical team and further education, can lessen the impact
of the disease. This care is, therefore, significantly different from the level of care type 1
diabetics receive, and the care that people with T1D require is often much more comprehensive
and intensive. By combining these data sources in existing research, individuals with type 1
diabetes are being overlooked, and do not receive adequate care when data is being used to
inform health programs and policies that will impact people with type 1 diabetes. This research
will address this issue by first only focusing on type 1 diabetes and the issues it poses in the
Dominican Republic, and second, by providing solutions to gaps in care that address the unique
issues facing type 1 diabetics in the Dominican Republic.
The second issue within existing research is not the aggregation of type 1 and type 2
diabetes (T2D) data, but the overall lack of type 1 diabetes-specific research to begin with. Most
likely because type 1 diabetes comprises only 5-10% of those with diabetes in the Dominican
Republic, as well as the nature of the disease being unpreventable, researchers tend to focus on
the disease (T2D) that is more prevalent and preventable. Within existing literature, researchers
can determine recent incidence rates of type 2 diabetes in the DR (there is none for T1D
available since the 1990s), and there is available research on other intersecting issues such as
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diabetes-related stress in the rural Dominican Republic (Gonzalez Rodriguez, et al., 2019), or the
effectiveness of specific type 2 diabetes programs in poorer regions of the DR (West-Pollak, et
al., 2014). Many of the issues that are analyzed would be important issues under a type 1
diabetes lens as well, however, this research simply does not exist in the abundance that type 2
diabetes research does.
Both of these issues; the aggregation of type 1 and type 2 diabetes data, and the lack of
specific type 1 diabetes research in the DR, have significant implications when pursuing policies
and programs that improve the level of care people with type 1 diabetes receive. Because poor
self-management of T1D can lead to adverse health outcomes, it is necessary to minimize these
through increasing access and communications with comprehensive care teams, incorporating
technology into treatment plans and providing affordable access to medication and procedures
for monitoring glucose levels (Duska, et al., 2021). However, if type 2 diabetes remains the focus
of research, these solutions will either cater to people living with type 2 diabetes with an
asterisk of type 1 or will entirely disregard the type 1 population in favor of serving the larger
population of diabetics. The solutions proposed in most literature on type 2 diabetes or
“diabetes” in general emphasize weight loss, exercise, diet, and additional medications, which
all refer to people living with type 2 diabetes.
Proposed programs include increasing access to healthier foods through community
gardens, or collaborating with small neighborhood stores to increase fresh food options
(Gonzalez Rodriguez, et al., 2018). Other solutions based on this literature include intervention
programs that train Dominican community members to advise others on issues such as healthy
nutrition, weight loss, and physical activity relating to diabetes or other “lifestyle modification”
programs (West-Pollack, et al., 2014). These programs are beneficial to Dominicans with
prediabetes or type 2 diabetes, but they do not provide solutions for individuals living with type
1 diabetes. While type 1 diabetics do need to maintain a good balance between nutrition and
exercise, this is in conjunction with insulin therapy, blood glucose monitoring, and other
complex topics that cannot be managed by community advisors or controlled with the addition
of community gardens. The existing literature primarily focuses on type 2 diabetes, and
therefore solutions to type 2 diabetes management and prevention. The current level of
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literature and data on type 1 diabetes is insufficient and does not allow for the same level of
analysis and interpretation that type 2 diabetes literature does. This research will fill in gaps in
existing type 1 diabetes literature and provide an analysis of potential improvements to the
current Dominican health system through a type 1 diabetes lens, as opposed to generalizing all
subsets of diabetes or adapting existing structures of type 2 diabetes care to fit the very
different needs of type 1 diabetics.

Healthcare and Society
The Dominican Republic guarantees quality healthcare to all Dominicans through Article
61 of their constitution under the “Right to health” (Dominican Republic's Constitution). The
article states that all Dominicans should have access to “means for the prevention and
treatment of all sicknesses, ensuring access to quality medication and giving medical and
hospital assistance for free to those who need it” (Dominican Republic's Constitution). While
the Dominican Republic guarantees access to healthcare, many Dominicans do not have access
to the quality providers, services, and medications they were promised. This lack of quality,
affordable, accessible care particularly impact patients who have chronic health conditions, as
conditions like type 1 diabetes require constant self-management and a lifelong reliance on the
healthcare system.
The structure of the Dominican healthcare system is complex and has been
experiencing a series of reforms throughout the last few decades aimed at achieving universal
healthcare for all citizens. Aiming to meet the United Nations Millennium Development Goals
(MDGs), much of these reforms focus on issues of equity, such as providing widespread primary
care health resources, improving accessibility to low-cost, high-quality medications, and
increasing health insurance coverage (Pan American). Following the passage of the General
Health Law in March of 2001, a series of reforms created the National Health System (NHS)
alongside the Social Security System, allowing the regulation of health activities by the State
(Pan American). These reforms develop principles of universal coverage and established
organizational bodies including the Bureau of Occupational Health and Safety (SISALRIL), the
National Health Insurance Authority (SENASA), and the Bureau of Consumer Information and
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Protection (DIDA), which began operations in 2002 (Pan American). Following these original
reforms, in 2005, a Strategic Agenda and Critical Roadmap for Health Reform was developed,
strengthening the Ministry of Public Health and Social Welfare (SESPAS), the organization of
public health programs and public health networks as well as ensuring principles of equity and
universal coverage for disadvantaged populations (Pan American). Since these reforms in the
early 2000s, healthcare coverage has increased to almost 70% of the population, from 21% in
2002 (Pan American). The most recent re-structures of the system aim to achieve universal
coverage through compulsory enrollment, comprehensive care, and gradual implementation
(Pan American).

Figure 2: Health System in the Dominican Republic (Rathe, 2018)

These healthcare reforms have created the Régimen Subsidiado, and the Regimen
Contributivo, or the Subsidized Regime and the Contributory Regime. The structure of the
system can be analyzed in Figure 2: Health System of the Dominican Republic, a map of the
healthcare system pictured above (Rathe, 2018). This diagram demonstrates the private and
public portions of the Dominican healthcare system and elaborates on its complexities. As
demonstrated in this diagram, the health system is split into two sections, private and public.
These are then further delineated by the next level of the Social Security Treasury (TSS) which
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finances both private and public health services. The low-income population is served via the
National Health Insurance Authority/National Health Service which purchases services (i.e. pays
for healthcare) from the public network (on the left side of the diagram) which is subsidized by
the Ministry of Public Health (Pan American). Aiming to insure the entire population, health
insurance is extended through public and private actors known as Health Risk Administrators
(ARS) (located in the middle and right side of the ‘Buyers’ diagram). ARS guarantees quality, and
timely care and aims to create efficient levels of care through contracts with health service
providers, both publicly and privately (Pan American).
The Subsidized Regime is subsidized through general taxes which contribute to a
common fund of Family Health Insurance that provides care to the lower-income populations
(Rathe, 2018). Whereas, the Contributory Regime is contributed to by individual firms and
households, usually through salary contributions from employees and by the employer. In
addition to the Social Security Treasury (TSS) within the public system, the private system can be
directly contributed to, to access only the private network as well.
While all Dominicans are guaranteed healthcare, the underinvestment in the public
system and network has led to the creation of a robust private healthcare system to fill these
gaps in care. Because the Dominican government has not significantly invested in their
healthcare system at the same level as both global and Latin American investments, many
Dominicans needed quicker, higher quality, and more accessible care that was not being
supported by the public sector. This need was filled by the private healthcare sector. In terms of
healthcare facilities, the majority of facilities in the DR are private (74%) (Ortiz, 2017), and the
private sector remains the preferred option for most patients due to the level of services and
options it provides (Rathe, 2018). For type 1 diabetes patients, in particular, supplies like insulin
pumps, continuous glucose monitors, and multiple daily injections are generally not available
within the public sector due to high costs, however, these management types provide superior
care to the management options in the public sector (fixed-dose management). This means that
regardless of one’s socioeconomic status and ability to pay, if one wants the best level of T1D
care, at the current care coverage and costs, they must invest in private healthcare.
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While health insurance coverage is provided to almost 70% of its citizens through the
Family Health Insurance plan, around three million people (27% of the population) were
uninsured in the DR in 2016 (Rathe, 2018). Many within the uninsured population are
considered vulnerable, yet do not meet the official poverty criteria to qualify for social benefits
due to their positionality within the informal sector (Rathe, 2018). Unable to qualify for
employer-based health insurance or state-subsidized programs, this gap in coverage leaves
many without access to the healthcare system (Rathe, 2018).This is a significant issue for the
DR, as most of those who cannot qualify are workers in the informal sector, and with around
47% of the working-age population acting as informal labor (ENFT), many workers are left
uninsured. Since healthcare coverage is greatly impacted by one’s socioeconomic status and
income, the healthcare system inequitably serves patients with higher incomes, who can afford
the high out-of-pocket costs or premiums. There have been some proposed reforms to address
the uninsured population, however, nothing substantive has occurred because of the proposed
reforms.

Arguments and Evidence
Type 1 diabetes is a chronic, autoimmune, lifelong condition, and those living with T1D
are heavily involved in the healthcare system. Successful T1D management includes regular
appointments with care teams, necessary education on how to inject insulin and test blood
glucose levels, and the required medical supplies and prescriptions. Therefore, a responsive,
well-funded, high-quality healthcare system is necessary to provide the support that those living
with T1D need to successfully manage their condition. However, currently, T1D patients in the
Dominican Republic are not receiving appropriate care to successfully manage their type 1
diabetes with high costs associated with care, geographic barriers, and overall underinvestment
in the Dominican healthcare system.

High Costs & Socioeconomic Implications
Globally, type 1 diabetes is one of the most expensive diseases to manage, with high
costs as a barrier to receiving care from endocrinologists and T1D care teams, as well as
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expenses related to insulin, supplies (syringes, glucose testing strips/meters), and T1D
technology (insulin pumps, continuous glucose monitors (CGMs)). There is a prominent
connection between socioeconomic status and one’s ability to regularly access medications like
insulin, and studies have highlighted how living with T1D in the DR has a detrimental impact on
T1D treatment adherence and quality of life (Gutiérrez Martinez, et al., 2021).
The consequences of these high costs, both with and without health insurance, result in
lower use of recommended diabetes technology like insulin pumps, continuous glucose meters
(CGM), and necessary supplies like insulin (Gutiérrez Martinez, et al., 2021). Depending on one’s
socioeconomic status, this under reliance on medical supplies is even more noticeable, as
patients whose income is less than 700 USD a month do not seek out as much medical attention
as they should due to high costs and are more likely to ration insulin (Gutiérrez Martinez, et al.,
2021). These high costs result in patients using their income instead of health insurance to buy
T1D supplies, with over half of patients claiming they had rationed insulin due to cost and over
two-thirds that had checked blood glucose less often than recommended due to costs
(Gutiérrez Martinez, et al., 2021). Rationing insulin, checking blood glucose less than
recommended and being unable to utilize technology like insulin pumps or CGMs (continuous
glucose meters) all contribute to worse type 1 management, leading to long-term health
complications and costs for both the patients and the healthcare system.
While there are few studies on the exact costs of insulin, the World Health Organization
estimates that for the Spanish Caribbean, the cost of insulin is around USD 159.50 (Barcelo, et
al., 2003). Similarly, the costs for fixed-dose management to insulin pump therapy range from
72.74 USD/month to 996.07 USD/month, resulting in an increased economic burden on patients
(Gutiérrez Martinez, et al., 2021). This impact of high costs is especially prevalent for patients
with lower incomes, as if family income is less than 40,000 DOP (Dominican Pesos), patients
experience less access to supplies, lower administration of insulin doses, less use of glucose
monitoring, and more cost-related factors that limit seeking medical attention (Gutiérrez
Martinez, et al., 2021).
Table 3 below further elaborates on the costs associated with different T1D treatment
regimens in the DR. FD (Fixed-Dose), which is the most affordable option for both private and
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public healthcare, is the only option for management within the public sector (Gutierrez
Martinez et. al, 2021). Fixed-dose regimen requires a specific amount of insulin to be given at
specific points during the day (such as meals), but the dose amount does not change depending
on carbohydrates, patients must instead manage their carbohydrate intake and decrease or
increase it depending on their range. This method is considered one of the least flexible
methods of management and compared to insulin pump therapy and multiple daily injections
(MDI), provides worse type 1 diabetes outcomes. Differing from the public sector, the private
sector offers fixed-dose (FD), multiple daily injections (MDI), and continuous subcutaneous
insulin infusion (CSII/insulin pump therapy). While the private sector provides the three main
methods of T1D management, these methods have different costs associated with them. CSII is
the most expensive, at almost USD 1000 a month, compared to $271 for MDI and $84 for a
fixed-dose regimen (Gutierrez Martinez et al., 2021). CSII has been shown to improve T1D
outcomes because it allows for more convenient and precise insulin dosing, yet it is extremely
costly in the DR, around 540% of the national minimum wage and 143% of the mean household
income (Gutierrez Martinez et. al, 2021).

Table 3: Total monthly cost of treatment (Gutiérrez Martinez, et al., 2021)
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Underinvestment in the Dominican Healthcare System
Related to high medication costs, the issue of private vs. public health insurance is
prominent in the type 1 diabetes community. Analyzing the use of private and public health
insurance, patients with type 1 diabetes who were using private health insurance were still
paying out-of-pocket costs, with less than 25% of supply coverage by insurance (Gutiérrez
Martinez, et al., 2021). Household out-of-pocket medical spending is high, especially for T1D
patients, and there remains a limited utilization of primary care centers, with specialized
hospitals and centers (Rathe, 2018). This underinvestment of the healthcare system arises
through the DR’s 6.1% of GDP investment in the healthcare sector, which compared to other
Latin American countries (8%) and globally (9.9%), is low (Gutiérrez Martinez, et al., 2021).
It was originally this underinvestment that spurred the private health sector in the DR, which
now disproportionately serves wealthier patients who can afford private healthcare.
T1D patients in the Dominican Republic are currently not receiving the level of care
necessary for successful self-management, especially highlighting the lack of clear,
comprehensive diabetes education programs upon diagnosis. When patients receive diabetes
education from trained professionals, they learn about insulin adjustments, carbohydrate
counting, use of glucose meters and other types of technology, and other critical aspects of
patient education that allow patients to self-manage their T1D to prevent serious health
complications (DiMeglio, et al., 2018). Yet, in the DR, only 29% of T1D patients are well
educated on type 1 diabetes, the lowest education rate out of nine countries surveyed across
Latin America (Gagliardino, et al., 2019), and studies have highlighted patients’ overall low
self-monitoring skills of their diabetes, potentially due to a lack of communication between
patients and care teams (Duska, et al., 2021). This lack of education is almost as dangerous as a
lack of access to insulin, supplies, and medical teams, as self-management is key to patients’
ability to manage insulin dosing and adjustments, carb counting, or glucose checks.
The current structure of the Dominican healthcare system forces T1D patients to choose
between paying high costs in the private sector and receiving higher levels of care or relying
solely on the public system using the FD regimen and compromising treatment flexibility and
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potentially long-term health outcomes. Further reforms of the healthcare system should reflect
changing this inequality in costs and choices, especially as the DR commits to providing
high-quality care for all citizens, regardless of their situation.

Geographic Barriers
Since very few studies on type 1 diabetes in rural regions in the Dominican Republic
exist, most research on geographic barriers examines type 2 diabetes, due to its high prevalence
rates in the DR. This research still holds merit when analyzing levels of care for type 1 diabetics,
as although the methods of management and care will differ between the two types of
diabetes, access to medications (like insulin), medical supplies, and medical professionals are
necessary for both type 1 and type 2 diabetics. By analyzing type 2 diabetes patients in rural
regions of the DR, this data highlights specific issues type 2 diabetic patients face, signaling the
potential for these issues to also be applied to type 1 diabetic patients in the DR.
Studies highlight that the main issues within rural regions in the DR are inaccessible
medications, supplies, and fewer medical professionals. Unaffordable medications impact
around 25% of rural communities, which is critical for patients living with type 1 diabetes who
need access to insulin and other medical supplies (Castro, et al., 2018). Regional inequalities
also highlight the distribution of most healthcare resources concentrated in the urban area of
Santo Domingo (Rathe, 2018). While the Dominican Republic has a typical ratio (2.1) of
physicians, this ratio does not take into account the rural and urban differences in care (Rathe,
et al., 2017). Since the ratio in the urban center of Santo Domingo is 5.1, the national average is
skewed, highlighting the distinct inequalities in care between rural and urban areas (Rathe, et
al., 2017).
In general, all Dominicans living in rural regions of the country receive worse care than
their urban counterparts. Since type 1 diabetics rely heavily on access to medications and
medical professionals, a lack of access for all Dominicans will greatly impact type 1 diabetics in
particular. The main issue impacting rural Dominicans seeking healthcare resources is the lack of
healthcare facilities in rural regions of the Dominican Republic (Carman, et al., 2003). Individuals
in rural Dominican regions are traveling twice as long to reach public healthcare facilities as
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their urban counterparts, and around four times as long to reach private healthcare facilities
(Thind, et al., 2003). This gap in care for rural Dominicans impacts patients living with type 1
diabetes in particular, as most access private care to maintain high levels of T1D management,
yet private care is even more unattainable in rural regions than public care. Overall, Dominicans
in rural regions don’t have the same level of access to medical facilities, professionals, and
medications and supplies that patients in Santo Domingo do, forcing patients to either
overcome these geographic barriers or receive less adequate or frequent care.

Case Studies
Attempting to address the issue of how the Dominican Republic can better meet the
health-related needs of its citizens with type 1 diabetes, comparable case study countries were
examined to better understand the impact of specific proposed solutions. Highlighting the
United States, Ecuador, Colombia, and a brief 9-country study, each case study emphasizes the
potential success of specific programs, policies, and investments to increase accessibility to T1D
care in the DR. The main solutions outlined include training of primary care providers (PCP) to
act as diabetes specialists in remote regions, virtual healthcare options, and diabetes education
programs.

PCP Trainings: Ecuador and the United States
As geographic location presents a large barrier for T1D patients in rural regions of the
Dominican Republic, solutions to these barriers include programs such as virtual healthcare or
telehealth, expanding the availability of T1D specialists, or training existing medical
professionals. Since primary care providers are generally untrained in the endocrine system,
most T1D patients must visit a T1D specialist or an endocrinologist, yet this can be inaccessible
for patients in rural regions or at medical centers with fewer resources. The training of PCP
providers can occur virtually or in person and provide ways for rural T1D patients to still receive
quality care.
In Ecuador and the United States, researchers analyzed the role of primary care
providers (PCPs) in providing enhanced T1D management for patients. The implementation of
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the Project ECHO (Extension for Community Health Outcomes) model aims to increase
confidence in primary care providers' management of complex T1D cases (Cuttriss, et al., 2021,
Walker, et al., 2021). In the United States, Project ECHO was implemented in ‘high need’ areas
of two states, with participating centers offering weekly virtual support in complex T1D
decision-making, a diabetes support coach, and online diabetes resources (Walker, et al., 2021).
Following the implementation of Project ECHO, PCP participants indicated high satisfaction with
the program with overall improvements in diabetes knowledge and confidence (Walker, et al.,
2021). As a recent program, the ECHO pilot program was successful in highlighting the proof of
concept for T1D PCP training programs to serve rural communities with scarce access to these
specialists.
Similarly in Ecuador, researchers used Zoom to recruit and train medical workers at 8
different primary care centers associated with the Ecuadorian public health system (Cuttriss, et
al., 2021). The same program, Project ECHO was implemented in each of these centers and was
the first pilot program to adapt the U.S. project to a Latin American country. Implemented in
2019, this program was unexpectedly suspended before the final collection of results due to the
COVID-19 pandemic. However, the participation of medical centers and professionals in
conjunction with the use of telemedicine highlights the existing interest in Ecuador. Additionally,
the success of Project ECHO in the U.S. emphasizes the pre-established success of this program
in reaching rural T1D patients, replicable in the Dominican Republic.

Virtual Healthcare/Telemedicine: Colombia
Ensuring type 1 diabetes healthcare is accessible to widespread T1D populations, virtual
healthcare/telemedicine provides alternative options of care for T1D patients who cannot see
medical providers in person. Researchers in Colombia analyzed this type of care through an
analysis of a virtual training program for patients upgrading to a hybrid closed loop (HCL) system
on insulin pump therapy (Gómez, et al., 2021). Implemented as a way for patients to receive
continuous care safely during the COVID-19 pandemic, this virtual training was conducted via
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Zoom and Medtronic’s CareLink System1. Since transitioning from a typical insulin pump to a
closed-loop system requires in-depth training by qualified medical professionals and data
follow-up appointments, COVID-19 presented a challenge to training T1D patients. Instead of
physical, in-person training and follow-up appointments, researchers conducted virtual sessions
on T1D education, and pump data interpretation skills provided by diabetes physicians, and
education/nutrition teams (Gómez, et al., 2021). Following these training sessions, patients
overall, experienced blood glucose levels in range, highlighting the success of virtual programs
as measured through health indicators, as well as the broader implications of patients not
needing physical, in-person training to achieve T1D goals (Gómez, et al., 2021). While this case
in Colombia specifically highlights the success of virtual insulin pump training, virtual healthcare
can be applied much broader to all types of type 1 diabetes care.

Diabetes Education: Colombia & 9-Country Comparison
While access to medical supplies and professionals is critical to proper T1D
management, well-rounded type 1 diabetes care includes high-quality education and training.
As a measurement of overall T1D healthcare access, researchers in Colombia analyzed the
health conditions of patients following the completion of diabetes education courses. Out of the
sampled patients, all recieved training on the use of insulin pumps, while around three-fourths
recieved additional training on diabetes basics such as carbohydrate counting, use of basal
rates, CGM data, etc. (Gómez, et al., 2013). Through this study, researchers found that
beginning insulin pump therapy improved T1D outcomes, but most importantly, lower A1C
levels were also improved with the completion of additional training on the devices and other
management skills (Gómez, et al., 2013). Overall, patient education in Bogotá in conjunction
with the use of diabetes technology led to reductions in HbA1c levels unachievable with insulin
pump therapy alone. This study in Colombia highlights the importance and effectiveness of
diabetes education in addressing health disparities in type 1 diabetic Dominicans.

1

Medtronic is a medical device company that manufacteres insulin pumps and diabetes technology. Medtronic
CareLink is software that analyzes raw data from insulin pumps, continuous glucose monitors, and blood glucose
meters.
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Focusing on a cross-regional analysis, a study across 9 Latin American countries
(Argentina, Chile, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, and
Venezuela), examined the impact of diabetes education, self-management, and glycemic control
on type 1 diabetes patients in Latin America. In addition to accessible medical supplies and
professionals, diabetes education similarly, had a positive impact on overall T1D management,
as T1D patients in this sample who recieved this education were more likely to meet their
HbA1c target goals (Gagliardino, et al., 2019). Following diabetes education, patients can
self-manage blood glucose and insulin intake, in addition to increasing knowledge in skills like
optimizing the use of T1D supplies and managing T1D throughout life events (Gagliardino, et al.,
2019). Increasing access to both widespread health coverage and diabetes education was
concluded to increase T1D care in Latin America, which can be more narrowly applied to the
Dominican Republic, which has one of the lowest diabetes education rates in the region
(Gagliardino, et al., 2019).

Implications and Recommendations
Type 1 diabetes patients in the Dominican Republic are experiencing lower levels of care
due to various factors, including high out-of-pocket costs for supplies, geographic barriers for
rural patients, and fewer resources from the Dominican government. Addressing these issues of
care, case studies in Colombia, Ecuador, and the United States highlight potential policy
solutions, programs, and investments that could be applied in the Dominican Republic. First, a
broader recommendation involves a restructuring of the Dominican healthcare system. The
current system has left around ⅓ of its population uninsured and therefore unable to receive
subsidized care. This impacts all Dominicans, but especially those who live with chronic
conditions like type 1 diabetes, as it requires high out-of-pocket costs that many type 1 diabetics
may not be able to afford. Secondly, even within this 70% of the population who are insured
(public, private, etc.), many patients still must pay exorbitant amounts for medical supplies and
insulin pump therapy. Addressing these issues, the Dominican government must look at a larger
restructuring of the system to insure this uninsured gap, in addition to more robust funding for
the public sector, making it more comparable to the private sector.
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Within this restructuring of the healthcare system, creating specific programs to address
gaps in T1D care would also aid in increasing accessibility and affordability. The first
recommendation is a standardized national type 1 diabetes education program that could be
offered both in-person and virtually for patients. Type 1 diabetes education programs are a
relatively low-cost and efficient way to increase overall T1D health and provide the skills
patients need to successfully manage their T1D. Since the Dominican Republic currently has one
of the lowest diabetes education rates in Latin America, increasing access to diabetes education
is the first step in increasing overall T1D care (Gagliardino, et al., 2019).
The second recommendation is to address the high costs of medical supplies and
out-of-pocket co-pays for patients with public and private health insurance alike. While this
could be partly addressed through the restructuring of the health system as addressed above,
specifically subsidizing high-cost treatments such as insulin pump therapy or fast-acting insulin
could increase supply access for T1D patients with lower incomes. Currently, patients with low
incomes on public health insurance only have access to lower-quality T1D treatments, which
only perpetuates health inequalities between Dominicans with higher and lower incomes. Since
treatments like insulin pump therapy result in better overall T1D outcomes, providing more
affordable access to these resources would create a more equitable medical system for type 1
diabetics.
The third recommendation is to reimagine medical provider visits and training, looking
to innovative solutions such as PCP training and virtual appointments/training to address gaps
in diabetes specialists and endocrinologists. With gaps in access due to geographic barriers,
income levels, and insurance types, training primary care providers on T1D management would
both increase the number of existing medical providers for T1D patients, but would also create
more accessible routes of care. Using programs like Project ECHO to train medical professionals
would increase provider confidence in managing cases, and allow patients to see medical
professionals that are geographically close to them. Additionally, providing options for virtual
training and care through telehealth platforms allows for similar growth in accessibility,
especially for patients in rural locations. Virtual training and appointments became increasingly
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popular during the COVID-19 pandemic, and since then, have provided a relatively affordable,
efficient way for providers to meet with patients.
Each of these recommendations addresses specific components of type 1 care inequities
in the DR, however, a combination of all approaches would provide the most robust solution for
these gaps in care. Each solution has its limitations, specifically in addressing the feasibility of
the program or policy. Primary care provider training will primarily target rural health
communities but will also require access to the internet and stable technology for medical
professionals to receive weekly training. This solution, therefore, requires adjustments for rural
areas that may not have high levels of technology and internet access. Second, virtual
healthcare is a solid solution for those who cannot travel to receive in-person care, but again,
relies on technology access which will consistently favor the wealthy. The incorporation of
virtual healthcare options would then necessitate additional ways for Dominicans with lower
incomes and fewer resources to still access virtual care, or utilize a different route of in-person
care. Lastly, while diabetes education does not need stable technology, it does require travel to
a specific location, and pre-existing knowledge and access to the medical system that provides
this education. Since each of these recommendations has limitations in terms of feasibility in
the DR, it is necessary to combine multiple approaches to address each specific need.

Conclusion
While the Dominican Republic has continually implemented healthcare reforms since
the early 2000s, the current system still does not fully support patients living with type 1
diabetes in the Dominican Republic. Largely due to high out-of-pocket costs for supplies,
geographic barriers to care, and overall underinvestment in the DR healthcare system, type 1
diabetes patients are both underserved and under-researched within the country. With severe
long-term health implications for substandard T1D care, it is integral both in the short-term and
long-term, that T1D patients have equitable access to affordable care and supplies.
Addressing T1D care in the DR requires further reforms of the existing healthcare
system, in addition to the implementation of T1D-specific programs and policies. These
strategies to increase T1D care include widespread type 1 diabetes education curriculum and
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programs, further training of primary care providers on type 1 diabetes specifically, and the
addition of telehealth as an option for routine T1D appointments and training. Moving forward,
the Dominican Republic must explore the implementation of these recommendations to ensure
they are providing access to high-quality medication and medical assistance to all, as is decreed
in the country’s constitution.
Lastly, limitations to this research include an overarching lack of data and research on
recent type 1 diabetes trends, treatments, and prevalence rates in the Dominican Republic.
Most research in the Dominican Republic focuses on the general topic of “diabetes” which
combines both types of diabetes or specifically type 2 diabetes, making research specifically on
type 1 diabetes difficult. Other limitations include the lack of primary data from type 1 diabetes
patients in the Dominican Republic, as collecting this data, either quantitative or qualitative
would provide a more robust understanding of the complexities of type 1 care in the DR.
Moving forward, additional research is necessary to better understand the situation of T1D care
in the DR, specifically regarding prevalence rates and trends, demographics, and other key
individual-level factors that may impact one’s access to care. Secondly, more research on the
effectiveness of the recommended programs (PCP training & Project ECHO, virtual healthcare,
and diabetes education) is necessary to understand what solutions provide the most efficient
routes of care and should be further expanded for T1D patients in the Dominican Republic.

Word Count: 8,517

29
Bibliography
2016 access survey. T1International. (n.d.). https://www.t1international.com/access-survey16/
Aschner, P., Aguilar-Salinas, C., Aguirre, L., Franco, L., Gagliardino, J.J., Gorban De Lapertosa, S.,
Seclen, S., and Vinocour, M. "Diabetes in South and Central America: An Update." Diabetes
Research and Clinical Practice 103, no. 2 (January 21, 2014): 238-43.
https://doi.org/10.1016/j.diabres.2013.11.010
Barcelo, A., Aedo, C., Rajpathak, S., &amp; Robles, S. (2003). The cost of diabetes in Latin
America and the Caribbean. Retrieved March 17, 2022, from
https://www.who.int/bulletin/Barcelo0103.pdf
Castro, B., Ing, L., Park, Y., Abrams, J., and Ryan, M., 2018. Addressing Noncommunicable
Disease in the Dominican Republic: Barriers to Hypertension and Diabetes Care. Annals of
Global Health, 84(4), pp.625–629. DOI: https://doi.org/10.29024/aogh.2370
Carman SK, Scott J. Exploring the health care status of two communities in the Dominican
Republic. International Nursing Review 2004; 51(1): 27-33.
Chan, Juliana C.N., Gagliardino, J.J., Baik, S.H., Chantelot, J.M., Ferreira, S., Hancu, N., Ilkova, H.,
Ramachandran, A. & Aschner, P. "Multifaceted Determinants for Achieving Glycemic
Control." Diabetes Care 32, no. 2 (February 2009): 227-33. doi:10.2337/dc08-0435.
Cuttriss, N., Naranjo, D., Goldring, M., Yabut, K., Figg, L., Baer, L., Mantilla, P., &amp; Flores, N.
(2021). ECHO model for type 1 diabetes (T1D) in Latin America: An Ecuadorian experience
during COVID-19. Pediatric Diabetes. Retrieved April 11, 2022, from
https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/p
t/covidwho-1228819
Darian-Smith, E., & McCarty, P. C. (2017). The Global Turn: Theories, Research Designs, and
Methods for Global Studies (1st ed.). University of California Press.
http://www.jstor.org/stable/10.1525/j.ctv1xxxs6
Dethlefs, H. J., Walker, E. A., Schechter, C. B., Dowd, R., Filipi, L., Garcia, J. F., & Filipi, C. (2019).
Evaluation of a program to improve intermediate diabetes outcomes in rural communities

30
in the Dominican Republic. Diabetes Research and Clinical Practice, 148, 212-221.
doi:https://doi-org.proxy.seattleu.edu/10.1016/j.diabres.2019.01.010
Diabetes in Latin America. Data from the International Diabetes Mellitus Practices Study
(IDMPS)." Diabetes Research and Clinical Practice 147 (2019): 47-54.
doi:10.1016/j.diabres.2018.08.007.
DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018). Type 1 diabetes. The Lancet,
391(10138),2449-2462. doi:https://doi-org.proxy.seattleu.edu/10.1016/S
0140-6736(18)31320-5
Dominican Republic's Constitution of 2015. (n.d.). Retrieved March 17, 2022, from
https://www.constituteproject.org/constitution/Dominican_Republic_2015.pdf
Duska, J., Hornsby, P.P., Pannone, A., Capra, J., Solano, N., et al. (2021) Demographic and Clinical
Characteristics of Youth with Diabetes in the Dominican Republic, 2000 to 2016. Int J
Diabetes Clin Res 8:137. https://doi.org/10.23937/2377-3634/1410137
ENFT (Encuesta Nacional de Fuerza de Trabajo [Labor Force Survey]). 2016. Santo Domingo:
Central Bank of the Dominican Republic.
Gagliardino, Juan José, Chantelot, J.M., Domenger, C., Ilkova, H., Ramachandran, A., Kaddaha,
G., Mbanya, J.C., Chan, J.& Aschner, P. "Diabetes Education and Health Insurance: How They
Affect the Quality of Care Provided to People with Type 1 Diabetes in Latin America. Data
from the International Diabetes Mellitus Practices Study (IDMPS)." Diabetes Research and
Clinical Practice 147 (2019): 47-54. https://doi.org/10.1016/j.diabres.2018.08.007
Brennan, A., & Heller, S. R. (2014). Substantial reductions in the number of diabetic ketoacidosis
and severe hypoglycemia episodes requiring emergency treatment lead to reduced costs
after structured education in adults with type 1 diabetes. Diabetic Medicine, 31(7),
847–853. https://doi.org/10.1111/dme.12441
Gómez, A. M., Grizales, A. M., Veloza, A., Marín, A., Muñoz, O. M., &amp; Rondón, M. A.

31
(2013). Factores Asociados con el control glucémico óptimo en pacientes tratados con
bomba de insulina y monitorización continua de glucosa en tiempo real. Avances En
Diabetología, 29(3), 74–80. https://doi.org/10.1016/j.avdiab.2013.04.001
Gómez, A. M., Henao, D., Parra, D., Kerguelen, A., Pinilla, M. V., Muñoz, O. M., &amp; Rondón,
M. (2021, January 5). Virtual training on the hybrid close loop system in people with type 1
diabetes (T1D) during the COVID-19 pandemic. Diabetes &amp; Metabolic Syndrome:
Clinical Research &amp; Reviews. Retrieved April 11, 2022, from
https://www.sciencedirect.com/science/article/pii/S1871402120305361
Gonzalez Rodriguez, H., Wallace, D. D., & Barrington, C. (2019). Contextualizing Experiences of
Diabetes-Related Stress in Rural Dominican Republic. Qualitative Health Research, 29(6),
857–867. https://doi.org/10.1177/1049732318807207
Gutierrez Martinez, A., Vargas Peña, C. N., Crespo Almonte, D., Romero Castro, N. E., Colón
Arias, F. A., & Gresse Júnior, S. (2021). Costs and economic impacts of type-1 diabetes from
the dominican patient perspective. Principles and Practice of Clinical Research, 7(2),
1–16.https://doi.org/10.21801/ppcrj.2021.72.1
Levesque, JF., Harris, M.F. & Russell, G. Patient-centred access to health care: conceptualising
access at the interface of health systems and populations. Int J Equity Health 12, 18
(2013). https://doi.org/10.1186/1475-9276-12-18
Ortiz, Altagracia. 2017. “El 65% de centros privados están habilitados,” Hoy, February 16.
Pan American Health Organization . (n.d.). Health Systems Profile Dominican Republic. PAHO .
Retrieved May 24, 2022, from
https://www.paho.org/hq/dmdocuments/2010/Health_System_Profile-Dominican_Republi
c_2007.pdf
Penchansky, R., & Thomas, J. W. (1981). The Concept of Access: Definition and Relationship to
Consumer Satisfaction. Medical Care, 19(2), 127–140.
http://www.jstor.org/stable/3764310

32
Rathe, Magdalena. "Dominican Republic: Can Universal Coverage Be Achieved?" World Health
Report Background Paper, 10 (2010): 2-19.
https://www.who.int/healthsystems/topics/financing/healthreport/DRNo10FINALV2.pdf.
Rathe, Magdalena. "Dominican Republic: Implementing a Health Protection System That Leaves
No One Behind." Universal Health Coverage Series, 30th ser. (2018): 3-41.
https://openknowledge.worldbank.org/bitstream/handle/10986/29182/122808-WP-RDC-D
R-ca se-study-pages-fixed-PUBLCI.pdf?sequence=1&isAllowed=y.
Thind, Andersen R. (2003) Respiratory illness in the Dominican Republic: what are the
predictors for health services utilization of young children? Social Science and Medicine,
56(6): 1173-1182.
Walker, A. F., Cuttriss, N., Haller, M. J., Hood, K. K., Gurka, M. J., Filipp, S. L., Anez-Zabala, C.,
Yabut, K., Roque, X., Wong, J. J., Baer, L., Figg, L., Bernier, A., Westen, S., Lewit, E., Sheehan,
E., Basina, M., Lal, R., Maizel, J., & Maahs, D. M. (2021). Democratizing type 1 diabetes
specialty care in the primary care setting to reduce health disparities: project extension for
community healthcare outcomes (ECHO) T1D. BMJ open diabetes research & care, 9(1),
e002262. https://doi.org/10.1136/bmjdrc-2021-002262
West-Pollak, A., Then, E. P., Podesta, C., Hedelt, A., Perry, M. L., Izarnotegui, W. V., . . . Taylor, A.
M. (2014). Impact of a novel community-based lifestyle intervention program on type 2
diabetes and cardiovascular risk in a resource-poor setting in the Dominican Republic.
International Health, 6(2), 118-124. doi:10.1093/inthealth/iht039
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes:
Estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5), 1047-53.
doi:http://dx.doi.org/10.2337/diacare.27.5.1047

